Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Haemophilus influenzae type B vaccine II DEC / 98
Halofantrine or its salts I DEC / 13
Halofuginone or its salts

For veterinary use.

I MAY / 18
Haloperidol I DEC / 13
Haloprogin III SEP / 98
Halothane I DEC / 13
Hemin I AUG / 18
Heparin and its salts. except for topical use II SEP / 99
Hepatitis A vaccine I FEB / 02
Hepatitis B Adult vaccine I FEB / 02
Hepatitis B Pediatric vaccine II DEC / 98
Hepatitis B immune globulin I FEB / 02
Hetacillin or its salts or derivatives

For veterinary use.

I DEC / 13
Hetastarch or its derivatives I DEC / 13
Hexachlorophene or its salts I DEC / 13
Hexacyclonate sodium I DEC / 13
Hexamethonium or its salts I DEC / 13
Histamine and its salts except for topical use II SEP / 98
Histrelin or its salts I DEC / 13
Homatropine and its salts for oral use in concentrations of 2 mg or less per dosage unit II SEP / 98
Homatropine and its salts for ophthalmic or parenteral use or in preparations for oral use containing more than 2 mg per dosage unit I SEP / 98
Human insulin II SEP / 98
Hyaluronic acid and its salts preparations in concentrations of 5% or more II SEP / 98
Hyaluronic acid or its salts

For veterinary use - when sold or recommended for administration by intra-articular injection to horses.

 

I DEC / 13
Hyaluronidase II SEP / 98
Hydralazine or its salts I DEC / 13
Hydrocortisone aceponate

For veterinary use.

I DEC / 13
Hydrocortisone or hydrocortisone acetate

When sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in children under 2 years of age.

I DEC / 14
Hydrocortisone or hydrocortisone acetate.

When sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in adults and children 2 years of age and over in package sizes containing more than 30 g.

I DEC / 14
Hydroquinone or its derivatives

When sold in a concentration less than or equal to 2% in preparations for topical use on the skin

II JUN / 19
Hydroquinone or its derivatives

When sold in a concentration greater than 2% in preparations for topical use on the skin.

I JUN / 19
Hydroxocobalamin or its salts

When recommended as an antidote for cyanide poisoning.

I DEC / 13
Hydroxychloroquine or its salts I DEC / 13
4- Hydroxycoumarin or its derivatives

Including but not limited to acenocoumarol when sold or recommended as anticoagulants.

I DEC / 13
Hydroxyephedrine and its salts II SEP / 98
Hydroxyurea I DEC / 13
Hydroxyzine or its salts or derivatives

Including but not limited to cetirizine and hydroxyzine hydrochloride. cetirizine or its salts when sold in concentration greater than 8.5 milligrams cetirizine per unit dose.

I DEC / 13
Hyoscine and its salts and derivatives [scopolamine] except Hyoscine butylbromide, when recommended for parenteral use II AUG / 16
Hyoscine butylbromide

When recommended for parenteral use.

I AUG / 16
Hyoscyamine and its salts and derivatives except for topical use II SEP / 98

40 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act